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Fig. 1. Supine abdominal plain film taken at 45 min after symptom onset, showing diffuse bowel
dilation, pneumatosis intestinalis (arrowheads), and portal venous gas (arrow). From “Fatal Clostridial
necrotizing enterocolitis in a term infant with gastroschisis” by Riggle, K. et al., 2016,
https://www.sciencedirect.com/science/article/pii/S2213576616301154. Copyright 2016 by Kevin
Riggle. Reprinted with permission.
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Identification

 Does the use of probiotics decrease the instance of
necrotizing enterocolitis (NEC) in neonates?

Records identified through
database searching
(n =32)

Additional records identified
through other sources
(n =0)

Screening

Records after duplicates removed
(n =25)

Fig. 2. A. Small bowel, in situ, with diffuse distention and dusky discoloration consistent with ischemia; B.
Microscopic image with severe mucosal necrosis and ischemic changes; C. Collections of “rod-shaped”
gram-positive bacilli present within the mucosa and submucosa. From “Fatal Clostridial necrotizing
enterocolitis in a term infant with gastroschisis” by Riggle, K. et al., 2016,
https://www.sciencedirect.com/science/article/pii/S2213576616301154. Copyright 2016 by Kevin Riggle.
Reprinted with permission.

METHODOLOGY

 An integrated review of the literature was
conducted using the methodology described by
Whittemore and Knafl (2005) and Brown
(2018).
 Cochrane, CINAHL, and Medline Complete
were searched using the following key terms
“probiotics”, and “necrotizing enterocolitis”, and
“reduction”.
 Search criteria was limited to “full text articles”
between the years 2013-2018 for all data bases.
 Inclusion criteria included studies involving the
evaluation of preterm infants only and specific
to probiotic effects on NEC.
 The original search identified a total of 32
articles. Of the 32 articles found, 7 were
duplicates and removed, and 13 were excluded
for various reasons; including, study focus not
on probiotics effect on NEC specifically, use of
other measures in addition to probiotics, focus
on infants with a certain disease process only, a
review of included article, not specific to
neonates, low level of evidence, and study of all
intestinal disease processes. Twelve met
specifications to be included in this review.
 All articles were critically analyzed using
evaluative checklists; PRISMA and Appendix A
and F of the appraisal Guide (Brown, 2018)
Findings from the studies were synthesized for
comparative analysis of results.

Eligibility

 Necrotizing Enterocolitis (NEC) is one of the
leading causes of infant mortality in premature
or low-birth-weight infants (AlFaleh et al.,
2014; Chang et al., 2017; Bernardo et al., 2013;
Meyer et al., 2017; Patole et al., 2016; AlFaleh
& Anabrees, 2014; Thomas et al., 2017; Uberos
et al., 2017; Fernandez-Carrocera et al., 2013;
Samuels et al., 2016; Repa et al., 2015; Oncel
et al., 2014).
 NEC is considered a medical emergency and is
the most common form of gastrointestinal
condition seen in neonates (Bernardo et al.,
2013).
 Approximately 27-63% of affected infants
require surgical intervention (Alfaleh &
Anabrees, 2014).
 NEC is associated by bowel wall necrosis and
can cause bowel perforation. It has been
reported to affect up to 10% of very low birth
weight infants (Alfaleh & Anabrees, 2014).
 The incidence of NEC greater than or equal to
stage 2 varies from 2.6-28% of low birth
weight infants, with associated mortality
ranging from 16-42% (Chang et al., 2017).
 Very low birth weight infants with NEC have a
mortality rate of up to 20% (Alfaleh &
Anabrees, 2014).

LITERATURE SEARCH FLOW
DIAGRAM
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Records screened
(n = 25)

Full-text articles assessed
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(n = 0)

Included

BACKGROUND & SIGNIFICANCE

Studies included in
quantitative synthesis
(meta-analysis)
(n =12)

Records excluded
(n =13)

Full-text articles excluded,
with reasons
Focus of study not on
probiotics effect on NEC
specifically(6), use of
other measures in
addition to probiotics(1),
too narrow of a
population (only look at
infant with certain disease
processes)(1), review of
included article(1), too
broad of population (not
all neonates)(2), low level
of evidence(1), study of all
intestinal disease
processes(1)

RESULTS
 Thirty two articles were initially identified;
Twelve included in final sample. Of the 12
articles, five were Level 1, two were Level 2,
and five were Level 4.
 Level of evidence rated using evidence pyramid
published by Long & Gannaway and Appraisal
Guides by Brown (2015; 2018).

LITERATURE SYNTHESIS
 Evidence suggests that the use of probiotics may
reduce the incidence of developing necrotizing
enterocolitis in infants born less than 32 weeks
gestation and/or less than 1500 grams.
 Nine of the twelve articles found significant
reduction in NEC with the use of probiotics in
neonates that were born less than 32 weeks
(AlFaleh et al., 2014; Chang et al., 2017;
Bernardo et al., 2013; Meyer et al., 2017; Patole
et al., 2016; AlFaleh & Anabrees, 2014; Thomas
et al., 2017; Uberos et al., 2017; FernandezCarrocera et al., 2013).
 Two studies found statistically insignificant;
both trials used the same strain of probiotic,
Infloran (Repa et al., 2015; Samuels et al.,
2016).
 Oncel et al. (2014) concluded that the strain L
reuteri did not effect the overall rates of NEC in
preterm infants.
 Four of the articles specifically reported the need
for more research in strain and dosage to be used
(AlFaleh & Anabrees, 2014; AlFaleh et al.,
2014; Chang et al., 2017; Thomas et al., 2017).
 Samuels et al. (2016) and Repa et al. (2015)
found that the type of feeding, whether
breastmilk or formula, altered the effectiveness
of the probiotics.

CLINICAL IMPLICATIONS
Necrotizing Enterocolitis in neonates could be
significantly reduced with the use of probiotics.

CONCLUSION
 Probiotics have been shown to reduce the
instance of NEC in preterm infants.
 More emphasis should be placed on the strain of
probiotic and the dosage needed to be effective.
 Additionally, more research is needed on the
effectiveness of probiotic use in infants born
before 27 weeks gestation.
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